EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $7,000 | -46.2% | 5,799 | +13.3% | 0.00% | – |
Q4 2021 | $13,000 | -43.5% | 5,117 | +13.6% | 0.00% | – |
Q3 2021 | $23,000 | -37.8% | 4,505 | 0.0% | 0.00% | – |
Q2 2021 | $37,000 | -5.1% | 4,505 | 0.0% | 0.00% | – |
Q1 2021 | $39,000 | -20.4% | 4,505 | 0.0% | 0.00% | – |
Q4 2020 | $49,000 | -9.3% | 4,505 | 0.0% | 0.00% | – |
Q3 2020 | $54,000 | -25.0% | 4,505 | 0.0% | 0.00% | – |
Q2 2020 | $72,000 | +2.9% | 4,505 | 0.0% | 0.00% | – |
Q1 2020 | $70,000 | -36.4% | 4,505 | 0.0% | 0.00% | – |
Q4 2019 | $110,000 | -20.9% | 4,505 | -59.4% | 0.00% | – |
Q2 2019 | $139,000 | +135.6% | 11,099 | +131.2% | 0.00% | – |
Q1 2019 | $59,000 | +110.7% | 4,800 | 0.0% | 0.00% | – |
Q4 2018 | $28,000 | -45.1% | 4,800 | 0.0% | 0.00% | – |
Q3 2018 | $51,000 | -21.5% | 4,800 | 0.0% | 0.00% | – |
Q2 2018 | $65,000 | -23.5% | 4,800 | 0.0% | 0.00% | – |
Q1 2018 | $85,000 | +41.7% | 4,800 | 0.0% | 0.00% | – |
Q4 2017 | $60,000 | -31.0% | 4,800 | 0.0% | 0.00% | – |
Q3 2017 | $87,000 | +20.8% | 4,800 | 0.0% | 0.00% | – |
Q2 2017 | $72,000 | -12.2% | 4,800 | 0.0% | 0.00% | – |
Q1 2017 | $82,000 | +41.4% | 4,800 | 0.0% | 0.00% | – |
Q4 2016 | $58,000 | -38.3% | 4,800 | -50.0% | 0.00% | – |
Q3 2016 | $94,000 | +91.8% | 9,600 | +100.0% | 0.00% | – |
Q2 2016 | $49,000 | -15.5% | 4,800 | 0.0% | 0.00% | – |
Q1 2016 | $58,000 | -24.7% | 4,800 | 0.0% | 0.00% | – |
Q4 2015 | $77,000 | +24.2% | 4,800 | 0.0% | 0.00% | – |
Q3 2015 | $62,000 | – | 4,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |